Please login to the form below
Values
This page shows the latest Values news and features for those working in and with pharma, biotech and healthcare.
Launch leaders' blog: what should launch leaders be measuring?
Payer, formulary and pricing/value discussions with how best to demonstrate the value of the new product.
Latest news
-
Perfect partners
Explain it, how it is set up and how the partnership is not inappropriately influencing opinion, but actually adding value to help improve patient health or well-being.
-
UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme
The scheme – first announced by Health Secretary Matt Hancock in 2019 – will pilot a model that reimburses pharma companies for antimicrobials based on a health technology value assessment of their value ... Shionogi strongly supports the
-
Novartis receives FDA breakthrough therapy designation for rare disease med
In this study, iptacopan significantly reduced proteinuria – a marker of inflammation in the kidneys – by 49% compared to baseline values at 12 weeks, in 12 patients with C3G.
-
Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal
Lilly will acquire Prevail for $22.50 per share in cash, plus one $4 contingent value right dependent on the first regulatory approval of a product from Prevail’s pipeline. ... For Prevail to achieve the full value of the contingent CVR payment, the
-
AstraZeneca takes home Company of the Year award at PMEA 2020
The companies respectively received a finalist and high commendation recognition. AstraZeneca's win in this category for 2020 reflects the company's commitment to customer-centricity and patient-focused values. ... However, it’s just one element of our
More from news
Approximately 38 fully matching, plus 2,390 partially matching documents found.
Latest Intelligence
-
The search for effective drug treatments for COVID-19
Although the price is significantly lower than the value the medicine represents for healthcare systems, this was the best way to prioritise speed of access for patients – making it an approach
-
Successful product commercialisation: what can we learn from the rare disease setting?
Furthermore, orphan drugs are anticipated to account for 55% of the EU pipeline’s cumulative value in 2022. ... Creating a compelling value story. Pricing and market access are evolving, with several trends emerging, including earlier and broad
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
In 2014-15, M&A deal values in this sector were $5bn, and in 2018-19, this surged 980% to a combined two-year total of $49bn.
-
Rebranding in an evolving world
Simultaneously, we are consistently searching for products that fit our brand and portfolio so that we can continue to expand and provide clear value to patients and healthcare providers. ... upon. A shift in culture. Our rebrand undeniably infiltrated
-
Unlocking the potential of precision medicine in oncology
Across our solid tumours portfolio, we are confident that our approach to precision medicine will deliver significant societal value, by optimising patient care through improving disease prevention, diagnosis and treatment. ... solutions that provide
More from intelligence
Approximately 21 fully matching, plus 679 partially matching documents found.
Latest appointments
-
Azafaros expands executive team with three senior hires
In this role, he led value-driven decisions analyses for the development portfolio, various clinical projects within therapeutic area franchises and strategic reviews.
-
Golin appoints new group managing director
of our exciting proposition and brilliant people; while creating efficiencies and value for clients.”.
-
Porterhouse announces members of medical advisory group
The group offers first-hand clinical experience to both colleagues and clients, adding value and insight into what resonates with health care professionals and patients.
-
New faces at Synergy Vision, Makara Health and JPA Health
Kate’s track record of delivering highly strategic, channel agnostic solutions along with her deep understanding across complex therapeutic categories will be of considerable value for our clients,” said Carrie Jones,
-
New hires at Abbott, Kite and Arrakis Therapeutics
The breadth of her expertise and her track record of creating value through focused drug development and creative business strategy will be tremendously important to Arrakis as we enter a period
More from appointments
Approximately 1 fully matching, plus 204 partially matching documents found.
Latest from PMHub
-
Live Webinar: COVID-19 Has Changed Live Events Forever!
Among other things, you will learn about the components of impactful virtual events, what aspects organizers and attendees value the most and why, how to track the success of the event
-
emotive appoints a Mental Health First Aider
We put a huge amount of value on the wellbeing of every colleague so we didn’t hesitate to join the MHFA England initiative to train one of our team as
-
Porterhouse Medical rewards superb client service skills
Her dedication to her accounts, combined with her passion and enthusiasm, embody our company values and enhance her ability to build strong relationships with key clients.
-
Modernising the Mental Health Act: Published Today
Around 150 recommendations for change in the comprehensive report were made, with key principles contributing to the overarching values to guide care and treatment. .
-
The emotive engagement gallery opens its doors for the first time
The event was also an opportunity to hand out our four Value Awards, awarded every 6 months to team members who have been voted on as most closely embodying our company ... values; Empowerment, Integrity, Collaboration and Imagination. .
More from PMHub
Approximately 19 fully matching, plus 624 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- PHE study finds people who have had COVID-19 can still transmit the virus
- New study identifies drugs that are safe to use in COVID-19 treatment
- UK pharmacies to begin administering COVID-19 vaccinations
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- New hire and promotions announced at Evoke KYNE
- The search for effective drug treatments for COVID-19
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Quick links
Infographics
